Review of vedolizumab for the treatment of ulcerative colitis
Michelle Sy Lau1, Her Hsin Tsai1
1Michelle SY Lau, Her Hsin Tsai, IBD Unit, Gastroenterology Department, Castle Hill Hospital, HEY NHS Trust, Cottingham HU16 5JQ, United Kingdom.
World Journal of Gastrointestinal Pharmacology and Therapeutics
|February 9, 2016
Abstract:
The review summarises the key data on the efficacy and the safety of vedolizumab in the management of ulcerative colitis.


